CMM Trademark

Trademark Overview


On Monday, September 13, 2021, a trademark application was filed for CMM with the United States Patent and Trademark Office. The USPTO has given the CMM trademark a serial number of 79323652. The federal status of this trademark filing is REGISTERED as of Tuesday, November 21, 2023. This trademark is owned by Indigo Diabetes N.V.. The CMM trademark is filed in the Medical Instrument Products category with the following description:

Medical devices and health monitoring devices, namely, sensors and instruments for the measurement of one or multiple metabolite levels of patients in the nature of patient monitoring sensors for medical use to be worn by and implanted in a human to gather human metabolomic data and optical, photonic and electrochemical patient monitoring sensors, patient monitors and spectrophotometer based optical and photonic patient monitoring sensor, patient monitor and instrument in the nature of patient monitoring alarms containing optical, photonic and electrochemical patient monitoring sensors and patient monitoring temperature sensors, patient monitoring heart rate sensors, blood pressure monitors; personal medical devices in the nature of portable and wearable and implantable sensors, monitors or instruments used to measure and gather metabolomic data for medical use and for identifying a physical or health state of a user, in the nature of a wearable wrist, ankle, torso monitor used to meas...
cmm

General Information


Serial Number79323652
Word MarkCMM
Filing DateMonday, September 13, 2021
Status700 - REGISTERED
Status DateTuesday, November 21, 2023
Registration Number7220328
Registration DateTuesday, November 21, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 5, 2023

Trademark Statements


Goods and ServicesMedical devices and health monitoring devices, namely, sensors and instruments for the measurement of one or multiple metabolite levels of patients in the nature of patient monitoring sensors for medical use to be worn by and implanted in a human to gather human metabolomic data and optical, photonic and electrochemical patient monitoring sensors, patient monitors and spectrophotometer based optical and photonic patient monitoring sensor, patient monitor and instrument in the nature of patient monitoring alarms containing optical, photonic and electrochemical patient monitoring sensors and patient monitoring temperature sensors, patient monitoring heart rate sensors, blood pressure monitors; personal medical devices in the nature of portable and wearable and implantable sensors, monitors or instruments used to measure and gather metabolomic data for medical use and for identifying a physical or health state of a user, in the nature of a wearable wrist, ankle, torso monitor used to measure biometric data for medical use and an implantable biofeedback sensor implanted subcutaneous, intramuscular, retroperitoneal, extravascular, intravascular, ocular, vesicular or in an organ; personal health monitoring and health controlling devices, namely, sensors and instruments for the measurements of one or multiple metabolite levels of patients in the nature of patient monitoring sensors, patient monitors and instruments in the nature of patient monitoring alarms for measuring one or more metabolite levels of patients being adapted for sensing, measuring and monitoring blood sugar and glucose and a parameter related thereto and for sensing, measuring and monitoring one or more metabolite levels of blood glucose, lactate, creatinine, trigluceride, protein, cholesterol, ethanol and a drug

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, October 26, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIndigo Diabetes N.V.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBE

Party NameIndigo Diabetes N.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE

Party NameIndigo Diabetes N.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events


Event DateEvent Description
Monday, March 18, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 22, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 22, 2024FINAL DISPOSITION PROCESSED
Wednesday, February 21, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 21, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, September 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 5, 2023PUBLISHED FOR OPPOSITION
Monday, September 4, 2023NOTIFICATION PROCESSED BY IB
Wednesday, August 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 16, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 16, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 5, 2023NEW REPRESENTATIVE AT IB RECEIVED
Saturday, July 29, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 28, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 28, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, April 12, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, March 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, February 8, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 8, 2023FINAL REFUSAL E-MAILED
Wednesday, February 8, 2023FINAL REFUSAL WRITTEN
Thursday, January 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 2, 2022REFUSAL PROCESSED BY IB
Tuesday, July 12, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, July 12, 2022REFUSAL PROCESSED BY MPU
Thursday, June 23, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, June 22, 2022NON-FINAL ACTION WRITTEN
Thursday, June 16, 2022ASSIGNED TO EXAMINER
Saturday, October 30, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, October 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 22, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB